N/A N=58 Pedicle Screw Usage in Conventional Fixation Pattern Constructs Compared to Thoracic Hook Constructs in Scoliosis
Adolescent Idiopathic Scoliosis
Primary: Main Thoracic Cobb — 55; 58; 15; 18 Degree
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 4 N=303 A Study to Evaluate the Safety of 3 New 6:2 Influenza Virus Reassortants in Adults
Influenza
Primary: Percentage of Participants Reporting Fever Within 7 Days Post Vaccination — 0.0; 1.7 Percentage of Participants
N/A N=160 Reducing Adverse Self-Medication Behaviors in Older Adults With Hypertension
Cardiovascular Diseases · Heart Diseases · Hypertension
Primary: Behaviors Risk Score — 17.9; 16.6; 16.4; 12.6 units on a scale — p=0.035
N/A N=108 Observational Study of Botox® Treatment for Patients With Upper Limb Adult Spasticity
Muscle Spasticity
Primary: Muscle Tone as Measured by the Modified Ashworth Scale (MAS) in the Elbow at Baseline — 2; 6; 18; 39 Participants
Phase 2 N=42 A Study of Flovent in Patients With Eosinophilic Esophagitis
Eosinophilic Esophagitis
Primary: Percentage of Participants Who Attained Remission. — 65.2; 0 percentage of participants
Phase 3 N=172 A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of the Sufentanil NanoTab PCA System/15 mcg (Zalviso™) for the Treatment of Post-Operative Pain in Patients After Open Abdominal Surgery
Post-Operative Pain
Primary: Time-weighted Summed Pain Intensity Difference (SPID) Over the 48-hour Study Period (SPID-48). — 105.60; 55.58 Units on a scale — p=0.001
Phase 3 N=126 Safety and Immunogenicity of a Cell Derived Subunit Trivalent Nonadjuvanted Influenza Study Vaccine in Adults Aged 18 Years and Above
Human Influenza
Primary: Percentage of Subjects With Single Radial Hemolysis (SRH) Areas ≥25mm2, Against Each of Three Vaccine Strains After Receiving One Dose of TIVc — 66; 41; 98; 84…
Phase 2 N=106 A Study of a Novel Investigational Drug in Rheumatoid Arthritis Patients (MK-0873-012)(COMPLETED)
Rheumatoid Arthritis
Primary: Change From Baseline in Swollen Joint Count — -7.20; -8.68 score on a scale — p=0.278
N/A N=22 Cryolipolysis and Subcision for Treatment of Cellulite
Cellulite
Primary: Blinded Rating of the Treatment Area (Cryolipolysis vs. Subcision) With the Best Cosmetic Appearance. — 22.22; 33.33; 44.44 Percentage of participants
N/A N=315 Varenicline or Nicotine Patch and Nicotine Gum in Helping Smokers in a Methadone Treatment Program Stop Smoking
Bladder Cancer · Cervical Cancer · Esophageal Cancer
Primary: Self- Reported 7-day Abstinence — 11; 3; 16 participants
N/A N=30 Fractional Laser and Ultrasound for Striae Distensae
Stretch Marks
Primary: Live-rater by Two Blinded Dermatologists — 77.27; 22.73 Percentage of participants
N/A N=50 Pre-op Use of Incentive Spirometry in Obese Patients
Lung Function · Bariatric Surgery
Primary: Post Operative Incentive Spirometry Volume — 1557.9; 1458.33 cc
Phase 2 N=46 Study of the MUC1 Peptide-Poly-ICLC Adjuvant Vaccine in Individuals With Advanced Colorectal Adenoma
Risk for Colorectal Cancer
Primary: Number of Participants With Anti Muc-1 Antibody — 39 participants
Phase 3 N=419 Efficacy and Safety Trial to Evaluate the Sufentanil NanoTab® PCA System/15 mcg (Zalviso™) for Post-Operative Pain in Patients After Knee or Hip Replacement Surgery
Post Operative Pain
Primary: Time-weighted Summed Pain Intensity Difference (SPID) Over the 48-hour Study Period (SPID48). — 76.24; -11.35 Units on a scale — p=<0.001
Phase 2 N=13 A Preliminary Study to Evaluate Cysteamine Therapy in Human Subjects With Non-Alcoholic Steatohepatitis (NASH)
Fatty Liver
Primary: Normalization or >50% of Serum ALT Levels From Baseline — 7 participants